Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
33 /100
MEDIUM RISK
Score updated Jul 28, 2026

FENC — Fennec Pharmaceuticals Inc. Dilution Risk Tracker

Track FENC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FENC — Get alerts when the score changes →

As of July 28, 2026, Fennec Pharmaceuticals Inc. (FENC) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. Fennec Pharmaceuticals Inc. has a market capitalization of $344.94M, 34.74M shares outstanding, 91 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄Convertible Debt

Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for FENC.
🔔 Track FENC — Get forecast alerts →

Market Data

Market Cap$344.94M
Shares Outstanding34.74M
Float16.88M
Cash$40.18M
Debt$26.00M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 14.6% shares (2026Q1 vs prior)
91 institutional holders · 17.87M shares
#1 Rosalind Advisors, Inc. 2.91M shares
#2 Southpoint Capital Advisors LP 2.74M shares
#3 Solas Capital Management, LLC 2.48M shares
+ 17 more holders Sign up free to view →

Short Interest

Short Interest609.2K
Days to Cover3.3
% of Float3.6%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-09-30
xbrl XBRL CONVERTIBLE 2013-12-31
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
Full SEC filing analysis available with free account

Recent News

No recent news

What This Means for FENC Shareholders

Fennec Pharmaceuticals Inc. (FENC) has a DilutionScore of 33/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 28, 2026.

DilutionWatch's EDGAR monitoring for FENC shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for FENC in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for FENC alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding FENC's Dilution Risk Factors

Primary Risk Drivers

The two most significant dilution risks for Fennec Pharmaceuticals Inc. stem from Offering Ability and Cash Runway scores. Offering Ability is currently at a moderate level, indicating that the company has the capacity to raise capital through equity offerings, which could dilute existing shareholders. The Cash Runway score of zero reflects an abundant cash position with no immediate liquidity concerns; however, this also implies the company may be in a stronger financial position to pursue additional funding, increasing the potential for future dilution.

Factors Currently Not a Concern

Float Risk and Warrant Exposure are currently low, indicating minimal risk from existing shares being traded or warrants converting into common stock. A change in either area would raise concern: an increase in Float Risk could occur if more shares become available for trading, perhaps due to new lock-up expirations or additional issuance. Warrant Exposure would become elevated if the company issues new warrants or if existing warrants are exercised at a higher rate than anticipated.

SEC Filings to Watch

Several SEC filings should be monitored closely for signs of increased dilution risk. An S-3 registration statement signals potential large-scale equity offerings, which could significantly impact share count. A 424B5 filing often accompanies equity offerings and provides details on the terms of new shares issued. An 8-K Item 1.01 disclosure may indicate a material event such as a new financing or strategic transaction that could affect ownership. Additionally, any 10-Q filings showing declining cash reserves or increased capital commitments should be reviewed for potential dilution triggers.

How Dilution Happens

Dilution occurs when the company issues new shares to raise capital or fulfill obligations. For instance, if Offering Ability is high, the company may issue new stock in a public offering, increasing the total number of shares outstanding and reducing each existing shareholder’s ownership percentage. If convertible notes convert into equity, those notes would also increase share count. The Cash Runway score being low suggests no immediate need for such actions, but an improving financial position could prompt future issuance, thereby increasing dilution risk.

What Would Make This Worse

The risk profile could deteriorate significantly if the company begins issuing convertible notes or warrants at a high rate, or if it files multiple S-3 offerings in a short time frame. A sudden drop in cash reserves could force the company to raise capital through equity issuance, increasing dilution pressure. Additionally, if existing shareholders begin exercising warrants en masse or if convertible notes reach their conversion triggers, this would sharply increase share count and reduce ownership percentages for current investors.

Key Insight

While a low Cash Runway score is generally safe, it indicates the company has no immediate cash concerns — which may make it more likely to pursue future capital raises, thereby increasing dilution risk over time.

How to Monitor FENC for Dilution Risk

What This Risk Level Means

For a small-cap operating company like Fennec Pharmaceuticals Inc., a medium dilution risk level signals that the firm has moderate exposure to potential equity dilution without being in immediate peril. Small-cap companies often rely on capital raises to fund operations and growth, making them more susceptible to dilution than larger firms. With a medium score, FENC is not currently under severe pressure, but it does carry enough risk that investors should remain vigilant about changes in capital structure or funding needs.

What Typically Happens Next

Companies at this profile often proceed with shelf registrations or ATM programs to raise capital. These mechanisms allow firms to issue shares on demand, which can increase the risk of dilution if not carefully monitored. Warrant exercises are also common for small-cap companies seeking to fund operations or repay debt. Given the elevated Offering Ability and Float Risk scores, it's likely that FENC may pursue some form of equity issuance in the near term, which could lead to further dilution unless properly managed.

Monitoring Playbook

To track FENC effectively, use DilutionWatch and set alerts for changes in key metrics such as offering ability, float risk, and warrant exposure. Monitor quarterly and semi-annual reports closely, especially around earnings announcements. Set a threshold of 5 points or more change in any key score to trigger an alert. Regular checks should be done every 2–4 weeks, with deeper dives when significant changes occur. If thresholds are met, review SEC filings for new equity offerings, warrant exercises, or changes in capital structure.

Early Warning Signals

Three critical early warning signals to watch for include: a sudden spike in Offering Ability score, an increase in the number of outstanding warrants, and a filing indicating a new shelf registration or ATM program. These events often precede dilution events and can be tracked via Shelf & ATM Monitor. Additionally, any change in the company’s capital structure reported in SEC filings should be reviewed carefully.

What a Positive Resolution Looks Like

A positive resolution would involve a capital raise that strengthens the balance sheet and reduces the need for further equity issuance. Alternatively, if warrants expire without being exercised, or if the company pays down debt using cash flow, these would lower the dilution risk score. A reduction in offering ability and float risk scores over time would also indicate improved financial stability.

Watch For

Any new SEC filings related to equity offerings or warrant exercises that may increase the company’s outstanding share count.

Full SEC filing analysis available with free account  →
Track FENC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FENC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for FENC
FENC FDA Catalyst Timeline & Biotech Grade — BiotechSignsFENC Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.